The research report on ventricular assist devices market categorizes the global market, by application (Bridge to Recovery, Transplantation Bridge and Destination Therapy), by product type, by design, and by region
Ventricular assist devices are external devices attached to a patient’s body, which helps to pump blood to whole body. It is principally used in case of patients with heart failure. It is a high-end device that mimics the function of the heart. Heart failure is a condition in which heart muscles weaken, and thus unable to pump sufficient amount of blood to body. Various conditions such as heart attacks, high blood pressure, defective heart valves, irregular heart rhythms, diabetes, and chronic kidney and lung diseases cause heart failure. Medication, implantable heart devices (pacemakers), and heart transplantation are some of the options for treatment of heart failure. However, these approaches have limitations that may lead to advanced heart failure condition, thereby increasing the demand for ventricular assist devices (VADs). VADs lowers the work load on failing heart and help in maintaining smooth blood flow to vital organs.
Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/1686
These devices were originally designed to temporarily assist surgeons while performing transplant surgeries or while treating other medical problems. However, VADs eventually emerged as a pioneer life support for patients suffering from the final stage of heart failure. VADs consist of three parts namely, inflow pipe that receives blood from ventricles, pump that pulls blood from ventricles and pushes it into outflow pipe that carries blood to aorta to supply blood to body
Market Dynamics
Growth of ventricular assist devices market is driven by increasing prevalence of heart failure. According to study the Global Burden of Disease published by the Lancet in 2017, globally over 26 million people were affected by heart failure. Moreover, rising prevalence of cardiovascular diseases, which causes heart failure, is increasing the demand for ventricular assist devices. According to World Health Organization factsheet in 2016, 17.7 million people die from cardiovascular disease each year, and over 46% of these deaths are due to ischemic heart disease that includes heart failure. Other disease such as diabetes is triggering to development of heart failure, which in turn, is propelling growth of the ventricular assist devices market. As per statistics provided by the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around 425 million patients were suffering from diabetes worldwide in 2017. According to statistics given by the American Heart Association in 2018, 68% of people suffering from diabetes aged 65 years and above are likely to die from heart disease. Sedentary lifestyle, lack of exercise, unhealthy food habits, and alcoholism are major cause to develop the heart disease. Growing shortage of heart donors for transplantation is also expected to boost growth of the ventricular assist devices market.
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/1686
According to report published by the Global Observatory on Donations and Transplantation in 2015, only around 0.01-0.49 per million heart transplantation procedures are performed each year in emerging countries due to shortage of donors. Continuous improvement in design, efficiency, and reliability is also propelling growth of the ventricular assist devices market. For instance, in April 2018, Abiomed Inc. was granted with U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella CP heart pump with smart assist technology, which utilizes an optical sensor. It is an advanced device that would improve productivity, ease in use, and better patient management.
Contact Us:
Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org/
Aspergillosis Treatment Market Opportunity Analysis, 2018-2026
Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.
Measles Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2018 – 2026
Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines.
PoC Platform & Technology Market to Surpass US$ 45.4 Billion by 2025
The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).
